Working… Menu

Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2 (Okgyn1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04928508
Recruitment Status : Not yet recruiting
First Posted : June 16, 2021
Last Update Posted : October 20, 2021
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Oklahoma

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : July 2023